Related Experiment Video
Updated: Aug 3, 2025

Stimulation of Cytoplasmic DNA Sensing Pathways In Vitro and In Vivo
Published on: September 18, 2014
STAT2 hinders STING intracellular trafficking and reshapes its activation in response to DNA damage
Chenyao Wang1,2, Jing Nan3, Elise Holvey-Bates4
1Department of Inflammation and Immunity, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH 44195.
Abstract:
In cancer cells, endogenous or therapy-induced DNA damage leads to the abnormal presence of DNA in the cytoplasm, which triggers the activation of cGAS (cyclic GMP-AMP synthase) and STING (stimulator of interferon genes). STAT2 suppresses the cGAMP-induced expression of IRF3-dependent genes by binding to STING, blocking its intracellular trafficking, which is essential for the full response to STING activation. STAT2 reshapes STING signaling by inhibiting the induction of IRF3-dependent, but not NF-κB-dependent genes. This noncanonical activity of STAT2 is regulated independently of its tyrosine phosphorylation but does depend on the phosphorylation of threonine 404, which promotes the formation of a STAT2:STING complex that keeps STING bound to the endoplasmic reticulum (ER) and increases resistance to DNA damage. We conclude that STAT2 is a key negative intracellular regulator of STING, a function that is quite distinct from its function as a transcription factor.
Insights
STAT2 negatively regulates STING signaling by blocking its trafficking, distinct from its transcription factor role. This prevents IRF3-dependent gene expression, enhancing DNA damage resistance in cancer cells.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- DNA damage in cancer cells can trigger cytoplasmic DNA sensing pathways.
- The cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING) pathway is activated by cytoplasmic DNA.
- STING activation is crucial for innate immune responses and anti-tumor immunity.
Purpose of the Study:
- To investigate the role of STAT2 in regulating STING signaling.
- To elucidate the mechanism by which STAT2 modulates STING-mediated immune responses.
- To determine if STAT2's function in STING signaling is linked to its known transcription factor activity.
Main Methods:
- Western blotting to assess protein phosphorylation and complex formation.
- Immunofluorescence microscopy to track STING intracellular trafficking.
- Reporter gene assays to measure IRF3 and NF-κB dependent gene induction.
- Analysis of STAT2 binding to STING in response to DNA damage.
Main Results:
- STAT2 binds to STING and inhibits its intracellular trafficking, suppressing IRF3-dependent gene expression.
- STAT2's regulation of STING is independent of tyrosine phosphorylation but dependent on threonine 404 phosphorylation.
- Phosphorylation of STAT2 at T404 promotes a STAT2:STING complex, retaining STING at the endoplasmic reticulum.
- STAT2 selectively inhibits IRF3-dependent genes, not NF-κB-dependent genes, in response to STING activation.
- STAT2 binding to STING enhances cellular resistance to DNA damage.
Conclusions:
- STAT2 acts as a novel, noncanonical negative regulator of STING signaling.
- STAT2's function in STING pathway regulation is distinct from its role as a transcription factor.
- STAT2-mediated inhibition of STING trafficking and IRF3 activation contributes to DNA damage resistance.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
The JAK-STAT Signaling Pathway
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Negative Regulator Molecules

